Timothy Daley
Stock Analyst at Wells Fargo
(2.03)
# 3,034
Out of 4,975 analysts
58
Total ratings
54.29%
Success rate
1.11%
Average return
Main Sectors:
Stocks Rated by Timothy Daley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $47 | $47.58 | -1.89% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $6.93 | +188.60% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $86.32 | +10.06% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $30.85 | +133.39% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $127.67 | +13.57% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,310.26 | -0.78% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $309.25 | -7.84% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $198.48 | +24.45% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $162.38 | +69.36% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $275.87 | -2.13% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $28 | $5.67 | +394.26% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $35 | $25.39 | +37.85% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $505 → $520 | $486.68 | +6.85% | 3 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $1.59 | +466.04% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $185 | $120.68 | +53.30% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $85 | $66.41 | +27.99% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $235 → $220 | $187.93 | +17.06% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $220 | $177.65 | +23.84% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $28 | $13.13 | +113.25% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $135 → $140 | $181.74 | -22.97% | 2 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $90 | $54.02 | +66.62% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $47
Current: $47.58
Upside: -1.89%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $6.93
Upside: +188.60%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $86.32
Upside: +10.06%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $30.85
Upside: +133.39%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $127.67
Upside: +13.57%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,310.26
Upside: -0.78%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $309.25
Upside: -7.84%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $198.48
Upside: +24.45%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $162.38
Upside: +69.36%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $275.87
Upside: -2.13%
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $5.67
Upside: +394.26%
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $25.39
Upside: +37.85%
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $486.68
Upside: +6.85%
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $1.59
Upside: +466.04%
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $120.68
Upside: +53.30%
May 2, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $66.41
Upside: +27.99%
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $187.93
Upside: +17.06%
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $177.65
Upside: +23.84%
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $13.13
Upside: +113.25%
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $181.74
Upside: -22.97%
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $54.02
Upside: +66.62%